Literature DB >> 31632572

Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2/MMP9-dependent manner.

Ji Xu1,2, Yajuan Yu3,4, Xujun He1,2, Nan Niu1,2, Xiao Li1,2, Renchao Zhang1,2, Junfeng Hu1,2, Jie Ma5, Xiaojun Yu1,2, Yuanshui Sun6, Haibin Ni6, Fengyong Wang6.   

Abstract

Cyclooxygenase-2 (COX2) and tumor-associated macrophages (TAMs) are associated with invasion, angiogenesis, and poor prognosis in many human cancers. However, the role of TAMs in human gastric cancer (GC) remains elusive. In the present study, we first measured COX2 expression and TAM infiltration in human GC tissues using double immunohistochemical staining. Then, we indirectly cocultured M2-polarized macrophages derived from human THP-1 cells with GC cells as an in vitro model. Transwell assays, siRNA transfection, treatment with a COX2 inhibitor and Western blotting were used to investigate the relationship among TAMs, invasion and COX2 expression as well as the underlying molecular mechanism. Double IHC staining showed that TAMs were aggregated near GC tumor nests and had high COX2 expression; moreover, the number of TAMs that infiltrated the tumor nest was correlated with the depth of invasion, COX2 expression and poor prognosis in human GC. In an in vitro assay, after treatment with phorbol myristate acetate (PMA), the THP-1 cells differentiated into M2 macrophages and induced COX2/MMP9-dependent invasiveness in GC cells. Pretreatment of GC cells with COX2 siRNA or a COX2 inhibitor (Celecoxib) can negate these promoting effects. The results of this study and those of our previous studies indicate that coculture with M2-polarized macrophages can induce the COX2-dependent release of matrix metalloproteinase-9 (MMP9), which subsequently increases the invasiveness of GC cells. Our data may provide a basis for targeting TAMs or for polarizing TAMs through immune regulation to halt GC progression, which could soon become a nonsurgical treatment for human gastric cancer. AJTR
Copyright © 2019.

Entities:  

Keywords:  COX2; TAMs; gastric cancer; invasion; poor prognosis

Year:  2019        PMID: 31632572      PMCID: PMC6789263     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  40 in total

1.  NO and COX2: Dual targeting for aggressive cancers.

Authors:  Daniel Davila-Gonzalez; Jenny C Chang; Timothy R Billiar
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-13       Impact factor: 11.205

2.  Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection.

Authors:  Heng Zhang; Xuefei Wang; Zhenbin Shen; Jiejie Xu; Jing Qin; Yihong Sun
Journal:  Gastric Cancer       Date:  2014-09-18       Impact factor: 7.370

3.  Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression.

Authors:  Johanna S M Mattsson; Bengt Bergman; Marianna Grinberg; Karolina Edlund; Millaray Marincevic; Karin Jirström; Fredrik Pontén; Jan G Hengstler; Jörg Rahnenführer; Mats G Karlsson; Christina Karlsson; Gisela Helenius; Johan Botling; Patrick Micke; Miklos Gulyas
Journal:  Cancer Lett       Date:  2014-10-31       Impact factor: 8.679

Review 4.  Gastric cancer - The role of matrix metalloproteinases in tumor progression.

Authors:  Marta Lukaszewicz-Zając; Barbara Mroczko; Maciej Szmitkowski
Journal:  Clin Chim Acta       Date:  2011-06-14       Impact factor: 3.786

Review 5.  Moving targets: Emerging roles for MMPs in cancer progression and metastasis.

Authors:  Gemma Shay; Conor C Lynch; Barbara Fingleton
Journal:  Matrix Biol       Date:  2015-01-31       Impact factor: 11.583

6.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1.

Authors:  Xu-Jun He; Hou-Quan Tao; Zhi-Ming Hu; Ying-Yu Ma; Ji Xu; Hui-Ju Wang; Ying-Jie Xia; Li Li; Bao-Ying Fei; Ya-Qing Li; Jian-Zhong Chen
Journal:  Cancer Sci       Date:  2014-10-23       Impact factor: 6.716

Review 8.  Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.

Authors:  Vladimir Riabov; Alexandru Gudima; Nan Wang; Amanda Mickley; Alexander Orekhov; Julia Kzhyshkowska
Journal:  Front Physiol       Date:  2014-03-05       Impact factor: 4.566

Review 9.  Tumor-associated macrophages as major players in the tumor microenvironment.

Authors:  Theerawut Chanmee; Pawared Ontong; Kenjiro Konno; Naoki Itano
Journal:  Cancers (Basel)       Date:  2014-08-13       Impact factor: 6.639

10.  The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients.

Authors:  Francesco Pantano; Pierpaolo Berti; Francesco Maria Guida; Giuseppe Perrone; Bruno Vincenzi; Michelina Maria Carla Amato; Daniela Righi; Emanuela Dell'aquila; Francesco Graziano; Vincenzo Catalano; Marco Caricato; Sergio Rizzo; Andrea Onetti Muda; Antonio Russo; Giuseppe Tonini; Daniele Santini
Journal:  J Cell Mol Med       Date:  2013-11-27       Impact factor: 5.310

View more
  22 in total

1.  Aiphanol, a multi-targeting stilbenolignan, potently suppresses mouse lymphangiogenesis and lymphatic metastasis.

Authors:  Shan-Mei Chen; Chuan-Ke Zhao; Li-Cheng Yao; Li-Xin Wang; Yu-Nan Ma; Lin Meng; Shao-Qing Cai; Cai-Yun Liu; Li-Ke Qu; Yan-Xing Jia; Cheng-Chao Shou
Journal:  Acta Pharmacol Sin       Date:  2022-07-01       Impact factor: 6.150

Review 2.  Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment.

Authors:  Daniel Fowler; Callum Nattress; Alba Southern Navarrete; Marta Barisa; Jonathan Fisher
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

3.  Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer.

Authors:  Lin Xin; Li-Qiang Zhou; Chuan Liu; Fei Zeng; Yi-Wu Yuan; Qi Zhou; Shi-Hao Li; You Wu; Jin-Liang Wang; Deng-Zhong Wu; Hao Lu
Journal:  EMBO Rep       Date:  2021-10-14       Impact factor: 8.807

4.  Effects of Cyclooxygenase-2 Inhibitors on Gastrointestinal Malignancies: a Systematic Review and Meta-analysis.

Authors:  Yuan-Xi Jiang; Ying Chen; Hui-Hui Sun; Shu-Chang Xu
Journal:  Indian J Surg Oncol       Date:  2022-05-10

Review 5.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

6.  Effects of Wild Yam Root (Dioscorea villosa) Extract on the Gene Expression Profile of Triple-negative Breast Cancer Cells.

Authors:  Elizabeth Mazzio; Abdulaziz Almalki; Selina F Darling-Reed; Karam F A Soliman
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

7.  An Analysis Regarding the Association Between the ISLR Gene and Gastric Carcinogenesis.

Authors:  Shu Li; Wei Zhao; Manyi Sun
Journal:  Front Genet       Date:  2020-06-16       Impact factor: 4.599

8.  Prognostic and Predictive Value of Cadherin 11 for Patients with Gastric Cancer and Its Correlation with Tumor Microenvironment: Results from Microarray Analysis.

Authors:  Zhijun Feng; Xue Li; Zhijian Ren; Jie Feng; Xiaodong He; Chongge You
Journal:  Biomed Res Int       Date:  2020-06-26       Impact factor: 3.411

9.  Cuban Brown Propolis Interferes in the Crosstalk between Colorectal Cancer Cells and M2 Macrophages.

Authors:  Yahima Frión-Herrera; Daniela Gabbia; Michela Scaffidi; Letizia Zagni; Osmany Cuesta-Rubio; Sara De Martin; Maria Carrara
Journal:  Nutrients       Date:  2020-07-09       Impact factor: 5.717

Review 10.  Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.

Authors:  Claudia Ceci; Maria Grazia Atzori; Pedro Miguel Lacal; Grazia Graziani
Journal:  Cancers (Basel)       Date:  2020-11-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.